{"id":"W2570216110","doi":"","title":"Cell death ELISAs in the phase I clinical evaluation of AEG35156 (XIAP antisense) administered as an intravenous infusion over 7-days, 3-days, and 2-hours.","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Apoptosis; Programmed cell death; Inhibitor of apoptosis; Pharmacology; Medicine; Cancer; Biology; Caspase; Cancer research; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001248354,0.0007395461,0.0005724377,0.000286365,0.0001834168,0.0004289859,0.0003741531,0.0006656839,0.001261293],"category_scores_gemma":[0.0005204277,0.0003068396,0.0003400811,0.0002623506,0.0003044739,0.0002214174,0.0001295986,0.001342619,0.000380877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005237809,"about_ca_system_score_gemma":0.0006355406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003181818,"about_ca_topic_score_gemma":0.0009103236,"domain_scores_codex":[0.9995415,0.0002157675,0.00002231618,0.00007472737,0.00009322376,0.00005256073],"domain_scores_gemma":[0.9997535,0.00004074285,0.00007970243,0.00002184036,0.00003616987,0.00006807921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08442383,0.02676062,0.006421475,0.0005193414,0.0002361012,0.0002504701,0.0002600163,0.004288862,0.7597671,0.000599883,0.003526381,0.1129458],"study_design_scores_gemma":[0.04657913,0.61599,0.02597025,0.0000532283,0.0003026325,0.001022629,0.0000905817,0.006047693,0.2915334,0.0003428328,0.01201493,0.00005280415],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9812298,0.003633447,0.006631024,0.0003003731,0.0001799509,0.003848181,0.001076372,0.0002253149,0.002875597],"genre_scores_gemma":[0.9806505,0.001473833,0.009444111,0.0004033428,0.00005486039,0.003095463,0.001564299,0.00002674353,0.003287005],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001261293,"threshold_uncertainty_score":0.006602049,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05674874129001793,"score_gpt":0.4219723944185894,"score_spread":0.3652236531285714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}